久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • Tolero Pharmaceuticals and AbbVie partner to develop AML therapy pharmaceutical
    August 22, 2018
    Biopharmaceutical firm Tolero Pharmaceuticals and AbbVie have formed a clinical research alliance to evaluate venetoclax and alvocidib combination for relapsed or refractory acute myeloid leukaemia (AML) treatment.
  • Astellas files experimental AML therapy pharmatimes
    April 27, 2018
    Astellas has filed its experimental Acute Myeloid Leukaemia (AML) therapy gilteritinib with US regulators, seeking approval for its use to treat FLT3 mutation-positive (FLT3mut+) relapsed or refractory forms of the blood cancer.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service